Patents by Inventor Martin Kipps

Martin Kipps has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240139397
    Abstract: The present invention relates to a method for temporarily interrupting an extracorporeal treatment of blood of a patient by use of a blood treatment apparatus. The method comprises activating or controlling a control device provided and configured to bring the blood treatment apparatus into a state in which the blood treatment session of the patient can be interrupted with the intention to continue the blood treatment session. The present invention further relates to a control device, a blood treatment apparatus, a digital storage means, a computer program product as well as a computer program.
    Type: Application
    Filed: January 11, 2024
    Publication date: May 2, 2024
    Inventors: Uwe Hermann, Sabine Kipp, Christine Nachbaur-Sturm, Thomas Pusinelli, Martin Gruendken, Georg Verch
  • Patent number: 11918724
    Abstract: This disclosure relates to a method for temporarily interrupting an extracorporeal treatment of blood of a patient by use of a blood treatment apparatus. The method comprises activating or controlling a control device provided and configured to bring the blood treatment apparatus into a state in which the blood treatment of the patient can be interrupted with the intention to continue the blood treatment. This disclosure further relates to a control device, a blood treatment apparatus, a digital storage means, a computer program product as well as a computer program.
    Type: Grant
    Filed: June 20, 2017
    Date of Patent: March 5, 2024
    Assignee: Fresenius Medical Care Deutschland GmbH
    Inventors: Uwe Hermann, Sabine Kipp, Christine Nachbaur-Sturm, Thomas Pusinelli, Martin Gruendken, Georg Verch
  • Publication number: 20060217402
    Abstract: This invention concerns new biocidal compounds of formula (I) wherein R is H or CH3. Of particular interest are two isomers that are named malayamycin A and desmethylmalayamycin A. These isomers, which may be prepared by growing under controlled conditions a previously unknown strain of micro-organism from the species Streptomyces malaysiensis, are characterised by nmr and mass spectroscopic data. They have biocidal activity, including anti-fungal, anti-viral and anti-cancer activity, and are of special interest for use in agriculture, horticulture, animal and human health.
    Type: Application
    Filed: January 3, 2006
    Publication date: September 28, 2006
    Inventors: Jill Benner, Bettina Gertrud Boehlendorf, Martin Kipps, Nicolas Eugene Lambert, Riet Luck, Louis-Pierre Molleyres, Snezana Neff, Traugott Schuez, Paul Stanley
  • Publication number: 20050096229
    Abstract: This invention concerns new biocidal compounds of formula (I) wherein R is H or CH3. Of particular interest are two isomers that are named malayamycin A and desmethylmalayamycin A. These isomers, which may be prepared by growing under controlled conditions a previously unknown strain of micro-organism from the species Streptomyces malaysiensis, are characterised by nmr and mass spectroscopic data. They have biocidal activity, including anti-fungal, anti-viral and anti-cancer activity, and are of special interest for use in agriculture, horticulture, animal and human health.
    Type: Application
    Filed: January 10, 2003
    Publication date: May 5, 2005
    Inventors: Jill Benner, Bettina Boehlendorf, Martin Kipps, Nicolas Lambert, Riet Luck, Louis-Pierre Molleyres, Snezana Neff, Traugott Schuez, Paul Stanley